CALCA and injury: These data indicated that KC protected against APAP-induced liver injury and the effects of KC, even at lower doses, was almost the same as silymarin, the well-known antidote used for treatment of liver injury [23,24], thus revealing the potential need for further investigation of KC as antidote for APAP-induced acute liver injury.